Skip to main content
. 2022 Jul 25;11(7):503–512. doi: 10.1302/2046-3758.117.BJR-2021-0358.R2

Fig. 6.

Fig. 6

a) Haemotoxylin and eosin (H&E) staining of the tendon-bone interface at two, four, and eight weeks after surgery in the secretory leucocyte protease inhibitor (SLPI) and negative control (NC) groups, respectively (n = 4). b) Masson’s trichrome staining of the tendon-bone interface of samples at two, four, and eight weeks in the SLPI and NC groups, respectively (n = 4). c) Modified Safranin-O/Fast Green staining of the tendon-bone interface at two, four, and eight weeks in the SLPI and NC groups, respectively (n = 4). IF, interface; T, tendon; arrow: cartilage-like cell, asterisk: neovascularization; bar 20 μm.